Results 11 to 20 of about 20,015 (227)

Extracranial, Extragonadal Germ Cell Tumors: A Multicenter Australian Case Series. [PDF]

open access: yesAsia Pac J Clin Oncol
Extragonadal germ cell tumors (EGCTs) are rare, with limited prospective data to guide treatment or inform prognosis. Incidence and treatment patterns of EGCT in Australia reflect international data and practices. Compared to testicular primaries, the prognosis of EGCT is poor, especially for primary mediastinal non‐seminoma.
Chow KVC   +19 more
europepmc   +2 more sources

Diagnostic performance of the microRNA-371a assay in small testicular masses: a real-world cohort study. [PDF]

open access: yesBJU Int
Objectives To evaluate the diagnostic performance of the Conformité Européenne [CE]‐certified microRNA‐371a‐3p (miR371a) assay in patients undergoing inguinal exploration for small testicular masses of unknown histology in a real‐world setting. Patients and Methods Between March 2023 and March 2024, 60 patients underwent inguinal exploration for ...
Seelemeyer F   +6 more
europepmc   +2 more sources

CHARACTERISTIC CHEMOTHERAPY RESPONSE OF TESTICULAR CANCER PATIENTS IN TERTIARY HOSPITAL

open access: yesJurnal Urologi Indonesia, 2022
Objective: The purpose of this study was to determine the correlation of testicular tumor markers on the success of chemotherapy in my institution.
Dio Mafazi Fabrianta   +2 more
doaj   +1 more source

CDKN2AIP-induced cell senescence and apoptosis of testicular seminoma are associated with CARM1 and eIF4β

open access: yesActa Biochimica et Biophysica Sinica, 2022
Testicular seminoma is a relatively rare tumor which is mostly detected in male population aged from 15 to 35 years old. Although several molecular biomarkers have been identified to be associated with testicular seminoma pathogenesis, the exact ...
Cao Yuming   +5 more
doaj   +1 more source

Single-Cell RNA Sequencing of Metastatic Testicular Seminoma Reveals the Cellular and Molecular Characteristics of Metastatic Cell Lineage

open access: yesFrontiers in Oncology, 2022
BackgroundTesticular cancer is the most common solid malignancy in young men. Given the many histological classifications of testicular tumors, seminoma is one of the most treatable cancers.
Linjian Mo   +15 more
doaj   +1 more source

Anaplastic seminoma [PDF]

open access: yesCancer, 1977
Eight patients with the diagnosis of anaplastic seminoma of the testicle were treated during the megavoltage era from January 1959 to January 1976. Two patients with Stage I disease and one patient with Stage IV disease have died from their malignancy.
M, Kademian   +3 more
openaire   +2 more sources

Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results [PDF]

open access: yes, 2016
Aim: To report long term oncologic outcomes after adjuvant radiotherapy (RT) for stage I seminoma. Method: We reviewed the complete data set for all patients treated at our institute between 1988 and 2005 for stage I seminoma with adjuvant RT after ...
De Felice, Francesca   +4 more
core   +2 more sources

Late recurrence of Seminoma in the pelvis: A case report

open access: yesUrology Case Reports, 2021
Recurrence of pure seminoma in atypical lymph node sites, such as the pelvis are rare masses that show clinical signs late in disease progression. We report a case of a 73-year-old male that presented with urinary retention and pain in his left lower ...
Seth Swinney   +3 more
doaj   +1 more source

Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS)

open access: yesSwiss Medical Weekly, 2018
BACKGROUND The majority of germ cell tumour (GCT) patients can be cured by orchiectomy followed by active surveillance or subsequent systemic and/or local treatments.
Christian Rothermundt   +21 more
doaj   +1 more source

Three-gene prognostic biomarkers for seminoma identified by weighted gene co-expression network analysis.

open access: yesPLoS ONE, 2020
Testicular germ cell tumors (TGCTs) are common in young males, and seminoma accounts for a large proportion of TGCTs. However, there are limited records on the exploration of novel biomarkers for seminoma.
Hualin Chen   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy